Literature DB >> 24519065

The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population.

Li Wang1, Zhenhong Chen, Yajuan Wang, De Chang, Longxiang Su, Yinghua Guo, Changting Liu.   

Abstract

Lung cancer is one of the most spread cancers in the world. The X-ray repair cross-complementing group 1 (XRCC1) gene plays an important role in the development of lung cancer. The objective of this study is to investigate the potential association of XRCC1 genetic polymorphisms with the susceptibility to lung cancer. In totally, 361 lung cancer patients (male, 276; female, 85; mean age, 62.55) and 361 cancer-free controls (male, 253; female, 108; mean age, 61.33) were enrolled in this case-control study. The genotypes of XRCC1 c.1471G>A genetic polymorphism were determined by the created restriction site-polymerase chain reaction (CRS-PCR) and DNA sequencing methods. The influence of XRCC1 gene on the susceptibility to lung cancer was analyzed by the analyses association. Our data indicated that significant differences were found in the frequencies of allelic and genotypic between lung cancer patients and cancer-free controls. The c.1471G>A genetic polymorphism was statistically associated with increased susceptibility to lung cancer [AA vs. GG: odds ratio (OR)=2.75, 95 % confidence interval (CI) = 1.55-4.88, P<0.001; AA vs. GA/GG: OR=2.69, 95 % CI=1.55-4.69, P<0.001; A vs. G: OR=1.37, 95 % CI=1.09-1.71, P=0.007]. The allele A and genotype AA may contribute to the susceptibility to lung cancer. Taken together, these results showed that the functional c.1471G>A genetic polymorphism of XRCC1 was associated with lung cancer susceptibility in the studied population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24519065     DOI: 10.1007/s13277-014-1702-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  40 in total

1.  The world health report 2002 - reducing risks, promoting healthy life.

Authors:  J J Guilbert
Journal:  Educ Health (Abingdon)       Date:  2003-07

2.  XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies.

Authors:  Liping Dai; Fujiao Duan; Peng Wang; Chunhua Song; Kaijuan Wang; Jianying Zhang
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

3.  An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.

Authors:  Dorota Butkiewicz; Marek Rusin; Bożena Sikora; Antonina Lach; Mieczysław Chorąży
Journal:  Mol Biol Rep       Date:  2010-12-28       Impact factor: 2.316

4.  DNA repair pathway genes and lung cancer susceptibility: a meta-analysis.

Authors:  Wusheng Li; Kai Li; Li Zhao; Huawei Zou
Journal:  Gene       Date:  2013-12-22       Impact factor: 3.688

5.  Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Yadong Wang; Haiyan Yang; Haishan Li; Li Li; Haiyu Wang; Cui'e Liu; Yuxin Zheng
Journal:  Cancer Lett       Date:  2009-05-28       Impact factor: 8.679

6.  XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures.

Authors:  Qin-xiang Guo; Wei-hua Yang; Jin-fang Zhai; Fu-cai Han; Chun-yan Wang
Journal:  Tumour Biol       Date:  2013-06-04

Review 7.  Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.

Authors:  Zhigang Cui; Zhihua Yin; Xuelian Li; Wei Wu; Peng Guan; Baosen Zhou
Journal:  BMC Cancer       Date:  2012-02-17       Impact factor: 4.430

8.  Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: Application of the additive model for cancer.

Authors:  Rebeca Pérez-Morales; Ignacio Méndez-Ramírez; Clementina Castro-Hernández; Ollin C Martínez-Ramírez; María Eugenia Gonsebatt; Julieta Rubio
Journal:  Genet Mol Biol       Date:  2011-10-01       Impact factor: 1.771

9.  Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer.

Authors:  Silvia Rybárová; Ingrid Hodorová; Jozef Muri; Jozef Mihalik; Marian Adamkov; Marián Svajdler; Dalibor Piovarci; Ladislav Mirossay
Journal:  Tumori       Date:  2011 Jan-Feb

10.  Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.

Authors:  M Felicitas López-Cima; Patricia González-Arriaga; Laura García-Castro; Teresa Pascual; Manuel G Marrón; Xose S Puente; Adonina Tardón
Journal:  BMC Cancer       Date:  2007-08-16       Impact factor: 4.430

View more
  3 in total

1.  The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population.

Authors:  Jun Tang; Jianzhu Zhao; Jungang Zhao
Journal:  Med Oncol       Date:  2014-08-22       Impact factor: 3.064

2.  Vascular endothelial growth factor polymorphisms and lung cancer risk.

Authors:  Junli Fan; Weiguo Zhang; Caipeng Lei; Bin Qiao; Qin Liu; Qiang Chen; Hongduo Jiao; Leizhen Jiang; Shuo Cui; Jianmin Chen
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  The programmed cell death 6 interacting protein insertion/deletion polymorphism is associated with non-small cell lung cancer risk in a Chinese Han population.

Authors:  Shu-Guang Liu; Shuang-Hu Yuan; Hui-Yong Wu; Cheng-Suo Huang; Jie Liu
Journal:  Tumour Biol       Date:  2014-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.